SESARAM
Funchal, Madeira, 9000-012, Portugal
NCT Number: NCT02539914
The purpose of this study is to determine whether it is feasible to use a virtual reality task for stroke rehabilitation for training motor and cognitive (attention and memory) domains based on the use of positive stimuli, and to evaluate the potential benefits in comparison to standard rehabilitation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Funchal, Madeira, 9000-012, Portugal
There is evidence that positive emotion stimuli can lead to improved performance in attention tasks and the investigators aim to understand the benefits of using this principle in cognitive and upper-limb motor rehabilitation following stroke. For this purpose, the investigators developed a VR attention task in which the user has to find a target image within a variable number of distractors by controlling a virtual arm. In some levels of the task the target has to be memorized, hence training both attention and memory. The target stimuli are positive images based on the individual preferences of each user.
40 participants within the first 6 months after stroke will be randomly allocated to one of two groups: 1) VR motor-cognitive task or 2) standard rehabilitation. The VR motor-cognitive task group will use the above described virtual task customized to each user in terms of the positive content. This also includes selected music that will be introduced in half of the sessions. The standard rehabilitation group will undergo conventional motor and cognitive rehabilitation. The intervention consists of 12 sessions of 45 minutes administered within a 4-6 weeks period. The participants will be evaluated using a number motor and cognitive assessment scales at baseline, end of the intervention and a 1-month follow-up.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Virtual reality based upper-limb motor and cognitive task
Standard upper-limb motor and cognitive rehabilitation tasks
Time frame: Baseline, End (4-6 weeks) and 4-weeks follow-up
Assessment of change from baseline in motor and joint functioning of the paretic upper extremity.
Time frame: Baseline, End (4-6 weeks) and 4-weeks follow-up
Assessment of change from baseline in the functionality of the paretic upper extremity.
Time frame: Baseline, End (4-6 weeks) and 4-weeks follow-up
Assessment of change from baseline in cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.
Time frame: Baseline, End (4-6 weeks) and 4-weeks follow-up
Assessment of change from baseline in independence in activities of daily living.
Time frame: Baseline, End (4-6 weeks) and 4-weeks follow-up
Assessment of change from baseline in muscle spasticity of the upper extremity
Time frame: Baseline, End (4-6 weeks) and 4-weeks follow-up
Assessment of change from baseline in muscle power of the paretic upper extremity.
Time frame: Baseline, End (4-6 weeks) and 4-weeks follow-up
Assessment of change from baseline in visual scanning deficits
Universidade da Madeira
Other
Interactive System for Diagnostics and Rehabilitation of Cognitive-motor Deficits: Controlled Longitudinal Clinical Study With Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details